Cytosorbents (CTSO) Total Debt (2016 - 2026)

Cytosorbents (CTSO) has 10 years of Total Debt data on file, last reported at $17.0 million in Q1 2026.

• For the quarter ending Q1 2026, Total Debt rose 19.54% year-over-year to $17.0 million; the trailing twelve-month figure through Mar 2026 stood at $17.0 million (up 19.54% YoY), and the FY2025 full-year result was $16.7 million, up 19.08% from the prior year.
• Total Debt for Q1 2026 stood at $17.0 million, up from $16.7 million in the prior quarter.
• Across five years, Total Debt topped out at $17.0 million in Q1 2026 and bottomed at $4.4 million in Q1 2024.
• The 5-year median for Total Debt is $13.8 million (2024), against an average of $11.0 million.
• The widest annual swing landed in 2023, when Total Debt increased 0.86%; it then soared 220.35% in 2025.
• A 5-year view of Total Debt shows it stood at $5.0 million in 2022, then rose by 0.86% to $5.0 million in 2023, then surged by 177.54% to $14.0 million in 2024, then advanced by 19.08% to $16.7 million in 2025, then climbed by 1.75% to $17.0 million in 2026.
• The last three Total Debt figures came in at $17.0 million (Q1 2026), $16.7 million (Q4 2025), and $14.6 million (Q3 2025), per Business Quant data.

Peer Comparison